India: Delhi High Court Restrains Natco From Dealing With Anti-Cancer Drug Olaparib - Anand & Anand

India: Delhi High Court Restrains Natco From Dealing With Anti-Cancer Drug Olaparib - Anand & Anand

Mondaq

Published

Delivering an injunction in favour of AstraZeneca, the Delhi High Court has restrained Natco from manufacturing and selling, or in any manner...

Full Article